Archive · 29 Jul 2025
Torrent Pharma Reports 20% Rise in Quarterly Net Profit
Torrent Pharma, a pharmaceutical company, made more money in the last three months.
Their profit went up by 20%, reaching ₹548 crore.
They also earned more money in India, the US, Brazil, and Germany.
This growth shows the company is doing well in selling its products, with the India and US markets performing particularly strong.
The company's overall financial health looks positive.
Torrent Pharma's net profit increased by 20% to ₹548 crore in the June quarter.
Revenue from operations rose to ₹3,178 crore.
India revenues increased by 11% year-on-year to ₹1,811 crore.
US business revenues grew by 19% year-on-year to ₹308 crore.
Shares of Torrent Pharma closed 0.75% higher on the BSE.
- Who
- Torrent Pharmaceuticals
- What
- Torrent Pharmaceuticals' consolidated net profit increased by 20% to ₹548 crore.
- When
- In the June quarter.
- Where
- Across various markets, including India, the US, Brazil, and Germany.
- Why
- Driven by strong sales across markets.
- Company
- Torrent Pharmaceuticals
- Net Profit (June Quarter)
- ₹548 crore (20% increase)
- Revenue (June Quarter)
- ₹3,178 crore
- India Revenue (June Quarter)
- ₹1,811 crore (11% increase)
- US Revenue (June Quarter)
- ₹308 crore (19% increase)
- Share Price (BSE)
- ₹3,629.50 (0.75% increase)
- Brazil Revenue (June Quarter)
- ₹218 crore (11% increase)
- Germany Revenue (June Quarter)
- ₹308 crore (9% increase)
